A European regulatory panel voted against approval of Biogen Alzheimer's disease drug, dealing a possible blow to the prospects of the drug already grappling with a slow rollout in the United States. Fred Katayama reports.
02:09
01:16
02:30
00:55
00:49
00:51
02:14
00:42
01:17
01:00
02:17
02:32
01:21
01:13
01:10
02:01
00:59
01:15
01:20
01:26
01:26
01:14
01:55
01:55
01:04
01:38
01:53
01:21
01:03
01:11
01:01
01:03
01:41
01:48
01:27
01:44
01:44
01:29
01:12
01:01
00:42
01:21
01:36
01:33
00:44
00:51
00:56
01:09
01:03
01:26
01:37
01:20
01:04
01:03
01:30
01:05
01:12
01:26
00:59
01:28
01:00
01:18
02:13
00:54
01:47
01:47
00:46
01:31
01:16
00:50
02:27
01:51
01:22
01:05
01:06
01:30
01:11
01:17
01:12
01:52
03:22
01:36
01:01
01:32
01:24
01:40
01:00
01:31
01:15
02:05
01:20
01:03
01:16
01:50
00:53
03:21
01:33
01:21
01:22
02:18